Avalo Therapeutics Inc. buy Oppenheimer Holdings Inc.
Start price
16.04.24
/
50%
€0.041
Target price
16.04.25
-
Performance (%)
-
End price
17.04.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avalo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 4,85 % | -2,75 % | 13,10 % |
| iShares Nasdaq 100 | 4,00 % | -3,33 % | 31,34 % |
| iShares Nikkei 225® | 4,22 % | -2,91 % | 44,47 % |
| iShares S&P 500 | 3,32 % | -2,95 % | 24,36 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics, Inc. (NASDAQ: AVTX) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating.
Ratings data for AVTX provided by MarketBeat
In the thread Trading Avalo Therapeutics Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten